Your browser doesn't support javascript.
loading
A European pharmacotherapeutic agent roflumilast exploring integrated preclinical and clinical evidence for SARS CoV-2 mediated inflammation to organ damage.
Singh, Yogendra; Fuloria, Neeraj Kumar; Fuloria, Shivkanya; Subramaniyan, Vetriselvan; Almalki, Waleed Hassan; Al-Abbasi, Fahad A; Kazmi, Imran; Rajput, Sobhit Singh; Joshi, Nirmal; Gupta, Gaurav.
Afiliación
  • Singh Y; Department of Pharmacology, Maharishi Arvind College of Pharmacy, Jaipur, India.
  • Fuloria NK; Faculty of Pharmacy, AIMST University, Bedong, Malaysia.
  • Fuloria S; Faculty of Pharmacy, AIMST University, Bedong, Malaysia.
  • Subramaniyan V; Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jenjarom, Selangor, Malaysia.
  • Almalki WH; Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Al-Abbasi FA; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Kazmi I; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Rajput SS; Aligarh College of Pharmacy, Aligarh, India.
  • Joshi N; Amrapali Institute of Pharmacy and Sciences, Haldwani, India.
  • Gupta G; Department of Pharmacology, School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India.
Br J Clin Pharmacol ; 88(8): 3562-3565, 2022 08.
Article en En | MEDLINE | ID: mdl-35352842

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Fosfodiesterasa 4 / Tratamiento Farmacológico de COVID-19 Límite: Aged / Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Fosfodiesterasa 4 / Tratamiento Farmacológico de COVID-19 Límite: Aged / Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: India